English – Page 1554 – TechStock²

Astera Labs (ALAB) Stock: Latest News, Analyst Forecasts, and Outlook (December 14, 2025)

Astera Labs (Nasdaq: ALAB) has seen sharp volatility in December. Here’s the latest news, Wall Street forecasts, and key catalysts investors are watching as of Dec. 14, 2025. ASTERA LABS, INC.+3StockAnalysis+3MarketBeat+3 Date: Sunday, December 14, 2025 (U.S. markets were closed; pricing reflects the most recent session). StockAnalysis+1 Astera Labs, Inc. (Nasdaq: ALAB) is back in the spotlight this weekend after a dramatic week of price swings and a fresh wave of commentary around AI data-center connectivity—especially how NVIDIA’s NVLink Fusion ecosystem and hyperscaler spending could reshape the interconnect landscape. StockAnalysis+2Business Insider+2 Below is a comprehensive, publication-ready roundup of the most

14 December 2025

NASDAQ:ALAB·Stock Market

Ripple Valuation Today (Dec. 14, 2025): Why Ripple Labs Is Being Priced Around $40 Billion—and What Could Move It Next

Updated: December 14, 2025 Ripple Labs’ valuation has become one of the most closely watched numbers in crypto-fintech—partly because Ripple is still private, and partly because 2025 has turned into a turning point for regulated stablecoins, institutional custody, and bank-style charters. As of today (14/12/2025), the clearest, most widely reported benchmark for Ripple’s company valuation remains about $40 billion, anchored by a $500 million strategic investment announced in early November and a $1 billion tender offer earlier in 2025 at the same valuation, according to Reuters. Reuters In the last few days, Ripple’s valuation conversation has intensified again—this time not

14 December 2025

Cryptocurrency·NYSE:FIG·NYSE:TRI

Arcus Biosciences (RCUS) Stock News, Forecasts and Analyst Targets — Dec. 14, 2025 Update

Arcus Biosciences, Inc. (NYSE: RCUS) is ending the weekend under a bright—and volatile—spotlight after a major clinical-program reset triggered a sharp Friday selloff. As of Sunday, December 14, 2025, the last reported close was $21.53, down 14.36% from the prior session, reflecting investor repricing after Arcus and partner Gilead halted a pivotal upper-GI cancer study. StockAnalysis What comes next for Arcus Biosciences stock now hinges less on TIGIT in gastric cancer and more on whether casdatifan can become a durable “anchor” asset in kidney cancer—and whether Arcus’ early move into inflammation and immunology can add long-dated upside without burning credibility

14 December 2025

Stock Market

Scale AI Valuation in 2025: Latest Read on the $29B Meta Deal, Private-Market Pricing Signals, and What Comes Next (Updated Dec. 14, 2025)

As of December 14, 2025, one question keeps surfacing across venture circles, secondary-market platforms, and AI industry chatter: what is Scale AI actually worth right now? The most recent widely reported headline number still points to about $29 billion, tied to Meta’s blockbuster minority investment and expanded commercial relationship with Scale AI in mid‑2025. Scale AI+1But in the past several days, fresh reporting and updated private-market pricing signals have pulled that figure into a much more complicated—and much wider—range. This is not unusual for late-stage private companies, but Scale AI’s case is especially volatile because the company sits at the

14 December 2025

Artificial Intelligence·NASDAQ:META

Sandisk (SNDK) Stock News Today: Downgrade Sparks Sharp Selloff, Analyst Price Targets, and 2026 Outlook (Dec. 14, 2025)

Published: Sunday, Dec. 14, 2025 (U.S. markets closed) Sandisk Corporation stock (NASDAQ: SNDK) heads into the Monday, Dec. 15 open with investors still digesting one of the biggest single-day drops among large-cap tech names this month—an abrupt reversal after a year defined by AI-driven enthusiasm, index inclusion, and a powerful memory-cycle rebound. Below is a complete, publication-ready roundup of today’s key headlines and context (Dec. 14, 2025), plus the latest analyst forecasts, price targets, and what to watch next. Sandisk stock price today: where SNDK stands on Dec. 14, 2025 Because today is Sunday, there is no regular-session trading in

14 December 2025

NASDAQ:SNDK

Oklo Inc. Stock (NYSE: OKLO) News, Forecasts and Analyst Outlook on Dec. 14, 2025 — ATM Offering, Sector Selloff, and What Investors Are Watching

Updated: December 14, 2025 Oklo Inc. (NYSE: OKLO) is ending the week at the center of a familiar high-volatility trade: advanced nuclear power as a potential solution for AI-era electricity demand—and the equally familiar pushback investors deliver when dilution risk rises. As of the last U.S. market close (Friday, Dec. 12, 2025), Oklo shares finished at $87.42, down 15.13% on the day, following a sharp weekly slide that market commentary tied to weakness across uranium and nuclear-linked stocks. StockAnalysis+1 Below is a detailed, publication-ready breakdown of today’s most relevant Oklo stock news, current forecasts, and the leading analyst narratives shaping

14 December 2025

NYSE:OKLO·Stock Market

Modine Manufacturing Company (MOD) Stock Today: What’s Driving the Sell-Off, Fresh Analyst Targets, and 2026 Outlook (Dec. 14, 2025)

Modine Manufacturing Company (NYSE: MOD) stock is in the spotlight on December 14, 2025 after a sharp pullback that abruptly interrupted a powerful 2025 rally. With markets closed for the weekend, the latest available pricing reflects Friday’s close: MOD ended at $139.88, down 15.32% on the session, after trading in a wide range and resetting near the lower end of its recent band. Investing.com That sudden drop has triggered a wave of fresh “what just happened?” searches—especially because Modine has been one of the more closely watched industrial names tied to data center cooling demand. Below is a roundup of

14 December 2025

NYSE:MOD·Stock Market

Anthropic Valuation 2025: Claude Maker’s $183B Price Tag Meets $300B+ Funding Talk as IPO Buzz Builds (Updated Dec. 14, 2025)

Anthropic—the AI company behind the Claude chatbot and Claude Code—has become one of the most watched private firms in tech, largely because its valuation is now being discussed in the same breath as the largest “frontier model” players on the planet. As of December 14, 2025, the most recently disclosed, official post‑money valuation for Anthropic remains $183 billion, set in its $13 billion Series F announced on September 2, 2025. Anthropic+1 But over the past two weeks, a rapid sequence of developments—IPO legal prep reports, new mega‑enterprise partnerships, an acquisition to bolster Claude Code, and fresh commentary questioning whether AI’s private valuations are “ahead of” public‑market reality—has intensified a

14 December 2025

Artificial Intelligence

Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)

Celestica Inc. (NYSE: CLS; TSX: CLS) is ending the week on a sharp down note after a steep tech-led selloff, even as new filings and fresh commentary published Sunday, Dec. 14, 2025 keep the company firmly in the spotlight for investors tracking AI data center infrastructure and hyperscaler spending. Below is a detailed, publication-ready look at today’s Celestica stock news, forecasts, and analysis, including what moved the shares, what Wall Street is modeling next, and the catalysts that could matter most into early 2026. Key takeaways for Celestica stock today Celestica stock price action: what happened into Dec. 14, 2025?

14 December 2025

NYSE:CLS·Stock Market·TSX:CLS

Databricks Valuation Today (14/12/2025): $134B Fundraising Talk, $100B Baseline, and What Investors Watch Next

Updated: December 14, 2025 (14/12/2025) Databricks has become one of the most closely watched private tech companies in the AI era—not because it builds chatbots, but because it sits underneath them. Its platform is where enterprises store, govern, process, and increasingly activate data for analytics and AI. That position at the center of “AI in production” is now showing up in the numbers investors care about most: valuation multiples, growth, and margin dynamics. Here’s the cleanest way to understand Databricks valuation today—what’s confirmed, what’s being reported, what secondary markets are signaling on December 14, 2025, and what could determine whether a rumored valuation

14 December 2025

xAI Valuation Today (Dec. 14, 2025): Why Elon Musk’s AI Startup Is Being Priced at $200B–$230B and What Comes Next

Updated: December 14, 2025 Elon Musk’s xAI has become one of the most closely watched private companies in the AI boom—and for one reason above all: valuation. In recent weeks, reporting has pointed to a fresh fundraising push that could lift xAI’s implied worth to about $230 billion, a level that would place it among the most valuable private technology companies on Earth. Reuters But “xAI valuation” in late 2025 is not a single clean number. It’s a moving target shaped by a mix of reported financing terms, secondary-market trading, capital-intensive infrastructure buildout, and fast-evolving product distribution through X, Tesla, and new international

14 December 2025

Artificial Intelligence·Elon Musk·NASDAQ:TSLA

SpaceX Valuation Surges to $800 Billion in Insider Share Sale—What the Latest IPO Forecasts Say for 2026 (Updated Dec. 14, 2025)

SpaceX’s valuation has vaulted to a new headline number: about $800 billion, after an insider share sale was set at $421 per share—a price outlined in a Dec. 12 letter from Chief Financial Officer Bret Johnsen that was reviewed by Reuters. The arrangement allows new and existing investors (and SpaceX itself) to purchase up to $2.56 billion worth of shares from eligible shareholders, giving employees and insiders a fresh liquidity window while also resetting expectations for what SpaceX could command if it enters public markets. Reuters+2Reuters+2 The timing is not an accident. Over the past week, a tight cluster of reports—from secondary-sale chatter to IPO “target window” briefings—has turned SpaceX valuation into one

14 December 2025

Stock Market·Technology

Previous 1 … 1,552 1,553 1,554 1,555 1,556 … 2,715 Next

Lumentum stock hits a record close — Citi raises target, insider filing lands ahead of Monday

7 February 2026

Lumentum shares jumped 9.3% to a record $551.99 Friday after Citigroup and JPMorgan raised price targets to $560 and $565. The surge followed strong quarterly results and guidance, plus a director’s filing to sell up to 4,849 shares. Markets reopen Monday ahead of the company’s March 17 investor briefing at OFC.

Nvidia stock price rebounds nearly 8% as AI spending race heats up — what to watch next week

7 February 2026

Nvidia shares jumped 7.9% to $185.41 Friday, their strongest gain in weeks, as chip stocks rallied on news of major AI infrastructure spending by Amazon and Alphabet. The PHLX semiconductor index rose 5.7%. Investors now await U.S. inflation data on Feb. 13 and Nvidia’s earnings report on Feb. 25.

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

7 February 2026

Lucid Group shares jumped 14% to $10.86 at Friday’s close, recovering from an 8% drop the previous day. The move followed a broad Wall Street rally that lifted high-volatility stocks. Lucid reported fourth-quarter deliveries of 5,345 vehicles and full-year deliveries of 15,841. Investors await Lucid’s Feb. 24 results for updates on cash and demand.

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

7 February 2026

Pfizer shares rose 2.8% to $27.22 Friday after the FDA granted priority review for a Hympavzi label expansion, with a decision expected in Q2 2026. Trading volume reached 50.7 million shares. The TrumpRx.gov drug-discount rollout put renewed focus on pricing, with over 30 Pfizer drugs listed at launch.

Stock Market Today